QurCan Therapeutics
fosters scientific creativity with pioneering nanotechnologies to accelerate advanced nanomedicines and improve patients’ quality of life.
QurCan Therapeutics is focused on the discovery and development of breakthrough therapeutics enabled by its proprietary nanotechnology drug delivery platform called “TERP”. We are committed to restoring health and transforming the lives of patients through the development of nanomedicine that requires the unique features of the TERP technology to address major unmet needs for the treatment of cancer and CNS diseases. |
CNS-Penetrating TERP |
TERP technology solves major hurdles in genetic medicine development, including the immunogenicity and high liver accumulation and toxicity associated with the existing technologies, while facilitating non-immunogenic and selective tissue targeting of nucleotides and other biological molecules, particularly to brain and spleen. |
Spleen-Specific TERP |
QUICK LINKSHome
Technology
Contact
|
LOCATIONS |